Sign in
Taking people in United StatesNo phase

Registry following teenagers with atopic dermatitis under dermatology care

Collects long-term information on how atopic dermatitis treatments are used in adolescents.

Key facts

Who runs it
CorEvitas
Where
Waltham, United StatesSee the site
Trial code
Registry title
CorEvitas International Adolescent Atopic Dermatitis (AD) Drug Safety and Effectiveness Registry
Status
Recruiting
People taking part
1,500 people, planned
Started
2 Dec 2023
Expected to end
31 Dec 2099
Type of study
Observational
Record updated
29 June 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The registry is looking for young people aged 10 to 15 with moderate to severe atopic dermatitis, diagnosed by a dermatologist or other qualified healthcare provider.

Age
10 to 15 years old at enrollment.
Sex
All sexes can join.
Disease stage
Moderate to severe atopic dermatitis.
Earlier treatment
The person has started, or is starting, a medication that qualifies for the registry at enrollment.

Main reasons for not taking part

  • Taking part in, or planning to take part in, a blinded clinical trial for an atopic dermatitis drug
  • Unwilling or unable to have standing height measured

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • To be eligible to participate in this registry, an individual must meet all the following criteria:; Has been diagnosed with moderate to severe atopic dermatitis by a dermatologist or a qualified healthcare provider; Is 10 - 15 years of age at the time of enrollment; Subject has initiated or is initiating an enrollment-eligible medication at the time of enrollment

Who cannot take part

  • An individual who meets any of the following criteria will be excluded from participation in the registry:; Is participating or planning to participate in a blinded clinical trial for an AD drug; Is unwilling or unable to provide standing height measurements

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 10 and 15 years old?

Where in United States

  • CorEvitas, LLCWaltham, United StatesContact: Cathy CheneyTaking people

About the trial

What the trial wants to find out

Prospective observational registry for an adolescent cohort with AD under the care of a dermatology provider. Approximately 1500 subjects and 75 clinical sites in North America and select European countries will be recruited to participate with no defined upper limit for either target.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
CorEvitas International Adolescent Atopic Dermatitis (AD) Drug Safety and Effectiveness Registry
Plain-language title
Registry following teenagers with atopic dermatitis under dermatology careGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT06238765, who can take part
Record updated
29 June 2026